SC 13G

Company

Nautilus Biotechnology, Inc.

Filed

August 13, 2020

Accession Number

0001193125-20-219155

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →